The Global Primary Cells Market is expected to grow significantly over the forecast period. It is estimated that the global primary cells market is expected to register a CAGR of ~ 9.5 % during the forecast period, from 2018 to 2023.
Primary human cells are the cells isolated directly from normal human tissues or blood cells via the enzymatic or mechanical method. Primary cells maintain their fundamental cellular functions hence, their use in cell-based research programs is increasing significantly. The rapid growth in biotechnology and biopharmaceutical industries, growing cancer research, increasing demand for monoclonal antibodies, and rising healthcare expenditure are anticipated to drive the growth of the market during the forecast period. Moreover, advantages of primary human cells over cell lines contribute to the growth of the market. For instance, endothelial cell lines, lack various functional markers, whereas primary endothelial cells retain these critical features. Despite these drivers, the high cost of advanced primary cells and risk of contamination may hamper the growth of the global primary cells market during the assessment period.
Lonza (Switzerland), Thermo Fisher Scientific (US), Merck KGaA (Germany), Cell Biologics (US), Promocell (Germany), ZenBio, Inc. (US), STEMCELL Technologies (Canada), ALLCells (US), American Type Culture Collection (ATCC) (US), and Axol Biosciences (UK).
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/6296
The Global Primary Cells Market has been segmented into origin, type, and end user.
The market on the basis of origin has been segmented into skin cells, hematopoietic cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart, skeletal and muscle cells, and others.
The market on the basis of type has been segmented into human primary cells and animal primary cells.
On the basis of end-user, the market has been segmented into research institutes and life science research companies.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The primary cells market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European primary cells market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The primary cells market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The primary cells market in the Middle East and Africa has been segmented into the Middle East and Africa.
Global Primary Cells Market, by Origin
Skeletal and Muscle Cells
Global Primary Cells Market, by Type
Human Primary Cells
Animal Primary Cells
Global Primary Cells Market, by End-User
Life Science Research Companies
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global primary cells market. The market growth in this region is attributed to the presence of a well-established healthcare system, increasing prevalence of cancer, growing government funding in research, and technological advancements. According to the National Cancer Institute, around 1,685,210 new cases of cancer were diagnosed in the US in 2016.
Europe is expected to be the second largest in the global primary cells market. It is expected that the government support towards research and development and growing prevalence of chronic diseases such as cancer are likely to drive the market growth in this region. According to the Office for National Statistics, the gross domestic expenditure on Research and Development (R&D) activities was Euro 33.1 billion (USD 35.2 billion) in 2016.
The primary cells market in Asia-Pacific consists of countries, namely, China, Japan, the Republic of Korea, India, and Australia. The market growth is mainly driven by rapidly expanding biopharmaceutical industries in the region, rising prevalence of cancer, growing pharmaceutical outsourcing, and increasing government funding in the life sciences sector. Moreover, countries such as India and China have established research institutes promoting cell-based research which contributes to the market growth.
The Middle East and Africa holds the lowest share of the global market owing to the slow economic development, lack of technical knowledge, and poor medical facilities.
Get Discount @ https://www.marketresearchfuture.com/check-discount/6296
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312